EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention

Maria Garcia-Gil, Lia Alves-Cabratosa, Oriol Cunillera, Jordi Blanch, Ruth Martí-Lluch, Anna Ponjoan, Francesc Ribas-Aulinas, Èric Tornabell-Noguera, Lluís Zacarías-Pons, Gina Domínguez-Armengol, Elizabeth Guzmán, Rafel Ramos iD

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Maria Garcia-Gil und 11 weiteren Autor:innen. Beteiligte Einrichtung: Grup Investigació en Salut Vascular de Girona (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Cat…. Hauptthemen laut MEDLINE: Cholesterol, LDL, Secondary Prevention, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: RedIAPP, RETICS, Instituto de Salud Carlos III- FIS grant, Instituto de Salud Carlos III- RICORS co-funded with European Union -Next GenerationEU funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effectiveness of statin treatment to reduce coronary events and mortality has been hardly examined considering goals of LDL‐C. We aimed to analyse such association in secondary cardiovascular prevention.

Methods

Retrospective cohort analysis of electronic health records from the SIDIAP database, Catalonia‐Spain. Recruitment period was from 2006 to 2017 and study period finished at the end of 2018. We included 54,175 people aged ≥35 years in cardiovascular secondary prevention starting statin treatment. We analysed the association of achieved LDL‐C goals after statin initiation with coronary heart disease and all‐cause mortality.

Results

Mean age was 69 years and 20,146 (37.2%) were women. Coronary heart disease occurred in 5687 (10.5%) participants, and 10,676 (19.7%) persons passed away. Median follow‐up lasted 5.7 years (interquartile range, 3.4–8.1). The coronary heart disease HRs (95% CI) for the LDL‐C goals of 70–100,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLSecondary PreventionHydroxymethylglutaryl-CoA Reductase InhibitorsCoronary DiseaseHumansFemaleMaleAgedMiddle AgedRetrospective StudiesCardiovascular DiseasesSpainCause of DeathGoals

Stichwörter der Autor:innen

cardiovascular diseaseelectronic health recordslow‐density lipoprotein cholesterol goalsreal‐world datasecondary cardiovascular preventionstatins

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Grup Investigació en Salut Vascular de Girona (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Catalunya, Spain.
  • Unitat de Suport a la Recerca Metropolitana Sud, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), l'Hospitalet de Llobregat, Spain.
  • Grup Investigació en Salut Vascular de Girona (ISV-Girona), Institut d'Investigació Biomèdica de Girona (IdIBGi), Catalunya, Spain.
  • Network for Research on Chronicity, Primary Care, and Prevention and Health Promotion (RICAPPS), Girona, Spain.
  • Departament de Ciències Mèdiques, Universitat de Girona, Catalunya, Spain.
  • Serveis d'Atenció Primària, Girona, Institut Català de Salut, Catalunya, Spain.

ORCID-Profile: Rafel Ramos

Förderung

  • RedIAPP, RETICS
  • Instituto de Salud Carlos III- FIS grant
  • Instituto de Salud Carlos III- RICORS co-funded with European Union -Next GenerationEU funds
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Instituto de Salud Carlos III

Zitieren

APA

Garcia-Gil, M., Alves-Cabratosa, L., Cunillera, O., Blanch, J., Martí-Lluch, R., Ponjoan, A., Ribas-Aulinas, F., Tornabell-Noguera, È., Zacarías-Pons, L., Domínguez-Armengol, G., Guzmán, E., & Ramos, R. (2024). Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14258

Vancouver

Garcia-Gil M, Alves-Cabratosa L, Cunillera O, Blanch J, Martí-Lluch R, Ponjoan A, et al. Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14258

BibTeX
@article{GarciaGil2024,
  author = {Garcia-Gil, Maria and Alves-Cabratosa, Lia and Cunillera, Oriol and Blanch, Jordi and Martí-Lluch, Ruth and Ponjoan, Anna and Ribas-Aulinas, Francesc and Tornabell-Noguera, Èric and Zacarías-Pons, Lluís and Domínguez-Armengol, Gina and Guzmán, Elizabeth and Ramos, Rafel},
  title = {Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14258}
}
Kostenlos starten →